Stock 300204 STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Equities

300204

CNE100001237

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
6.36 CNY +1.92% Intraday chart for Staidson (Beijing) BioPharmaceuticals Co., Ltd. -1.40% -37.40%
04-24 Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-25 Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Staidson's Respiratory Drug Shows Safety in Trial
MT
Staidson Forms R&D Deal With Germany’s InflaRx
MT
Inflarx Gmbh and Staidson Biopharmaceuticals Co., Ltd Enters into Third Addendum to the Co-Development Agreement
CI
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Staidson Beijing Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Staidson Beijing Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Staidson Beijing Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Staidson Beijing Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
Staidson Beijing Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
Staidson Biopharma and Pivotal Enter into Agreement for Covid-19
CI
Staidson Biopharmaceuticals Co., Ltd. Approves Cash Dividend For 2019
CI
Staidson Beijing Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300204 Stock
  4. News Staidson (Beijing) BioPharmaceuticals Co., Ltd.
  5. Highlights